Searchable abstracts of presentations at key conferences in endocrinology

ea0037ep678 | Pituitary: basic and neuroendocrinology | ECE2015

Long-term safety, tolerability, and efficacy of extended release somatostatin analogues

Gonzalez Javier , Garcia-Centeno Rogelio , Arnoriaga Maria , Picallo Maria , Ramirez Maria Laura , Andia Victor Manuel , Olmedilla Yoko Lucia , Lopez Aurelio , Monereo Susana

Introduction: The main indications for the somatostatin analogues (SST-A) are acromegalies and/or neuroendocrine tumors. They can increase fecal fats, which could lead to the loss of fat soluble vitamins. There are few published studies showing the effects of the long-term use.Methods: Retrospective study of patients with SST-A indicated from our endocrinology department in the last 10 years. We analysed indications and different epidemiological, clinica...

ea0035p237 | Clinical case reports Pituitary/Adrenal | ECE2014

Hyperprolactinemia secondary to primary hypothyroidism with hyperplasia pituitary

Centeno Rogelio Garcia , Melero Victor Andia , Fernandez Elisa Fernandez , Salas Marcel Sambo , Gonzalez-Antiguedad Cynthia , de la Camara Marta Motilla , Solis Diego Lezcano , Gonzalez Javier , Rivadeneira Lenin , Requena Maria , Ramirez Maria Laura , Olmedilla Yoko , Arnoriaga Maria

Introduction: Although the most common causes of hyperprolactinemia are prolactinoma and iatrogenic, another possible cause is severe primary hypothyroidism, in which the increase of prolactin is a cause of pituitary stimulation by TRH, and can be presented with pituitary hyperplasia.Case report: A 31-year-old woman who comes to endocrinology clinic for hyperprolactinemia, which was detected by symptoms of amenorrhea–galactorrhea. After normal pregn...

ea0028p134 | Growth and development | SFEBES2012

Growth hormone (gh)-transgenic mice exhibit gh-stat5 insensitivity associated with up-regulation of negative signaling modulators

Martinez Carolina , Piazza Veronica , Miquet Johanna , Ramirez Maria , Becu-Villalobos Damasia , Bartke Andrzej , Turyn Daniel , Sotelo Ana

JAK2/STAT5 is the principal growth hormone (GH) signaling pathway related to body growth. It is positively regulated by glucocorticoid receptor (GR) and hepatocyte nuclear factor 1 (HNF-1) and downregulated by activation of tyrosine-phosphatases SHP-1,-2 and PTP-1B, and by GH-induction of suppressors of cytokine signaling (CIS/SOCS) that block GHR or JAK2, and promote internalization/degradation of signaling complexes. This pathway is desensitized in liver of adult transgenic ...

ea0035oc12.5 | Pituitary Basic | ECE2014

Does hypercortisolism of Cushing’s syndrome affect telomere length?

Aulinas Anna , Ramirez Maria Jose , Barahona Maria Jose , Valassi Elena , Resmini Eugenia , Mato Eugenia , Santos Alicia , Crespo Iris , Bell Olga , Surralles Jordi , Webb Susan

Introduction: Hypercortisolism in Cushing’s syndrome (CS) determines increased mortality and morbidity. Hypercortisolism is also present in chronic depressive disorders and stress, where telomere length (TL) is shorter than in controls. We hypothesized that telomere shortening may occur and contribute to premature morbidity in CS.Aim: Investigate TL in CS compared to matched controls, and longitudinally in a subset of CS patients evaluated both with...

ea0035p445 | Diabetes complications | ECE2014

Autoimmune pancreatitis after intravenous insulin desensitization in a diabetic patient allergic to insulin without pancreatic reserve

Salas Marcel Sambo , Melero Victor Andia , Ishishi Yoko Olmedilla , Centeno Rogelio Garcia , Ramirez Maria Laura , Motilla Marta , Antiguedad Cynthia Gonzalez , Requena Maria , Lopez Javier Gonzalez , Rivadeneira Lenin , Arnoriaga Maria

Introduction: Allergy is an uncommon side-effect of insulin treatment in which desensitization represents an alternative when initial approaches are not effective. Autoimmune pancreatitis (AIP) is an even more rare disease that generally has a successful response to corticosteroids. The case of a 50-year-old diabetic man who developed both processes sequentially is presented.Case report: The patient was admitted for acute diabetes mellitus (DM) decompens...

ea0032p873 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Relationship between telomere length and dyslipidemia in patients with Cushing's syndrome

Aulinas Anna , Jose Ramirez Maria , Jose Barahona Maria , Mato Eugenia , Bell Olga , Valiente Cristian , Valassi Elena , Resmini Eugenia , Santos Alicia , Crespo Iris , Corcoy Rosa , Surralles Jordi , Webb Susan M.

Introduction: Cushing’s syndrome (CS) is associated with increased mortality and morbidities. Hypercortisolism is also present in chronic mood disorders (CMD) and stress, where telomere length (TL) has been found to be shorter than in matched controls. Since hypercortisolism is present in CS and CMD, we hypothesized that telomere shortening could also be present in CS. The aim of this study was to investigate TL in CS patients compared to matched controls.<p class="ab...

ea0099p334 | Pituitary and Neuroendocrinology | ECE2024

Prognostic value of the pituitary apoplexy score for predicting hormonal and visual recovery of patients with pituitary apoplexy: results from a spanish multicentric study

Noelia Sanchez Ramirez Maria , Perez Carlos , Paredes Igor , Acitores Cancela Alberto , Garcia Feijoo Pablo , Alvares Escola Cristina , Calatayud Maria , Soledad Librizzi Maria , Lagares Alfonso , Rodriguez Berrocal Victor , Araujo Castro Marta

Aim: Evaluate the predictive value of the Pituitary Apoplexy Score (PAS) for predicting hormonal and visual recovery after surgery or conservative management of patients with pituitary apoplexy (PA).Methods: Multicenter retrospective study of patients presenting with clinical PA in three Spanish tertiary hospitals between 2008 and 2022. The PAS was calculated following the UK Pituitary Apoplexy Guidelines Development Group evaluation grid.<p class="a...

ea0099ep1093 | Adrenal and Cardiovascular Endocrinology | ECE2024

Metyrapone treatment for mild autonomous cortisol secretion (MACS) - a case report

Manuel Ruiz-Canovas Jose , Pascual-Corrales Eider , Aracely Achote-Rea Estefania , Madrid-Egusquiza Imanol , Noelia Sanchez-Ramirez Maria , Anabel Idrobo-Zambrano Cindy , Garcia-Regal Carlos , Maria Jimenez-Cassinello Jose , Vega-Beyhart Arturo , Araujo-Castro Marta

A 68-year-old man with history of non-muscle-infiltrating bladder tumor and atrial fibrillation was referred to the Endocrinology Department in November 2020 for a functional study of a left adrenal incidentaloma. Furthermore, the patient had a history of arterial hypertension diagnosed at the age of 45 years, on treatment with 3 drugs (enalapril 20 mg B.I.D., amlodipine 5 mg B.I.D., hydrochlorothiazide 12.5 mg/day), achieving usual blood pressure (BP) levels of 150/90 mmHg. A...